Magali Vidal

Magali Vidal

Auto-generated profile, based on publicly available information

Magali Vidal

Department of Infectious and Tropical Diseases, University Hospital of Clermont-Ferrand , 63100 Clermont-Ferrand

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
TKThibault Kerdiles
Thibault Kerdiles
SLSophie Lejeune
Sophie Lejeune
APAntoine Portais
Antoine Portais
GBGaelle Bourgeois
Gaelle Bourgeois
BLBenjamin Lefevre
Benjamin Lefevre
JTJulie Traclet
Julie Traclet
Nocardiosis, a bacterial opportunistic infection caused by Nocardia spp, has recently been reported in patients with anti–granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies, but insufficient data are available about disease presentation, outcomes, and occurrence of autoimmune pulmonary alveolar proteinosis (aPAP) in this population. We performed a prospective, multicenter, nationwide study in France and included patients with a Nocardia infection who had anti-GM-CSF autoantibodies. We describe their clinical, microbiological, and radiological characteristics, and their outcome at 1 year of follow-up. Twenty patients (18 [90%] male) were included, with a median age of 69 (interquartile range, 44–75) years. The organs most frequently involved were the brain (14/20 [70%]) and the lung (12/20 [60%]). Half of the infections were disseminated (10/20 [50%]). Nocardia identification was predominantly made in abscess fluid (17/20 [85%]), among which 10 (59%) were brain abscesses. The 1-year all-cause mortality was 5% (1/20), and only 1 case of aPAP (1/20 [5%]) occurred during the follow-up period. Nocardiosis with anti-GM-CSF autoantibodies is associated with a low mortality rate despite a high incidence of brain involvement. Although the occurrence of aPAP was infrequent during the 1-year follow-up period, long-term clinical data are needed to fully understand the potential relationship between nocardiosis, anti-GM-CSF autoantibodies, and aPAP.

9 March 2022 in Journal of Infection
Verified
Journal Article
Closed access
BBBenjamin BONNET
Benjamin BONNET
HCHélène Chabrolles
Hélène Chabrolles
CAChristine Archimbaud
Christine Archimbaud
ABAmélie Brebion
Amélie Brebion
MGMaud Godignon
Maud Godignon
CHCécile Henquell
Cécile Henquell

1 May 2021 in Infectious Diseases Now
Verified
Journal Article
Closed access
BCB. Castagné
B. Castagné
MSM. Soubrier
M. Soubrier
JPJ. Prouteau
J. Prouteau
NMN. Mrozek
N. Mrozek
OLO. Lesens
O. Lesens
MVM. Vidal
M. Vidal

28 December 2024 in Clinical Therapeutics
Verified
Journal Article
Open access
MCMélissa Clément
Mélissa Clément
FAFlorence Anglade
Florence Anglade
LGLucie Gibold
Lucie Gibold
DMDelphine Martineau
Delphine Martineau
CDClaude Dubray
Claude Dubray
MVMagali Vidal
Magali Vidal
High doses of amoxicillin are recommended to treat severe infections such as endocarditis. Amoxicillin causes dose-dependent toxicities, in particular crystal nephropathy. Toxicity could be avoided by monitoring of amoxicillin trough plasma concentrations (ATPC). However, the relevance of ATPC testing in routine medical practice remains poorly studied. We conducted a prospective clinical trial in adults treated with high doses of discontinuous intravenous amoxicillin in a French university hospital. The primary outcome was the distribution of ATPCs over three days during the first week of treatment. Urine tests for amoxicillin crystalluria (AC), pH, and density were also performed. Seventy patients were included. Overall intra-class correlation (ICC) was 0.35 IC95% [0.21; 0.53] with the following pairwise concordances: D1-D4 (n= 55) 0.23 IC95% [-0.02; 0.47], D1-D7 (n= 47) 0.41 IC95% [0.19; 0.63], and D4-D7 (n= 50) 0.17 IC95% [-0.10; 0.43]. Inter-individual variability was also significant, with coefficients of variation being 0.87 at D1, 1.20 at D4, and 1.35 at D7. AC occurred in 32 patients (47.8%). Risk of AC increased when pH was below or equal to 6 (P = 0.002). ATPCs were higher in patients with AC and/or acute kidney injury. Variability in ATPC was high and ATPC cannot be considered as the only monitoring tool to adjust amoxicillin dosage. High ATPC, low urinary pH, and presence of AC can alert physicians to a potential iatrogenic effect and lead to the decision to hydrate the patient, alkalinize urine and decrease the dosage of amoxicillin.

18 June 2026 in Brain
Verified
Journal Article
Closed access
NLNicolas Lambert
Nicolas Lambert
MMMajdouline El Moussaoui
Majdouline El Moussaoui
AGAdèle Le Guilloux
Adèle Le Guilloux
MJMarine Joly
Marine Joly
MMMaria del Carmen Garcia Martearena
Maria del Carmen Garcia Martearena
GMGuillaume Martin-Blondel
Guillaume Martin-Blondel
Despite improved survival in recent years, long-term outcomes in patients surviving progressive multifocal leukoencephalopathy (PML) beyond the first year remain poorly defined. This international multicentre retrospective study aimed to characterize the 3-year prognosis of patients with PML who had survived at least 1 year, identify factors associated with favourable outcomes and late mortality, and determine recurrence rate. Data were collected through standardized questionnaires across 41 centres in 11 countries. Patients were eligible if they met the 2013 Diagnostic Criteria for Definite PML of the American Academy of Neurology, survived at least 1 year after diagnosis, and had documented follow-up 3 years after diagnosis. Demographic, clinical, virological and radiological data were retrieved at diagnosis, 1 year and 3 years. Functional status was assessed using the modified Rankin Scale, with scores of 0–2 defining a favourable outcome. Generalized linear mixed models identified independent predictors of 3-year functional status and late mortality. Of 1877 screened cases, 245 patients met inclusion criteria. The most common underlying causes of immunosuppression were HIV infection (48%), autoimmune/inflammatory diseases (26%) and haematological malignancies (18%). At 3 years, 220 patients (89.8% of the cohort) were alive and 188 (85.5% of survivors) had neurological sequelae, most frequently motor or cognitive impairment. Overall, 112/245 (45.7%) achieved a favourable functional outcome. HIV-associated PML [odds ratio (OR) 2.36, 95% confidence interval (CI) (1.05–5.28)] was associated with a favourable outcome, whereas higher modified Rankin Scale score at diagnosis [OR 0.48, 95% CI (0.35–0.66)] and higher number of affected brain regions on baseline MRI [OR 0.78, 95% CI (0.64–0.95)] were independently associated with poorer functional outcome. Among variables collected 1 year after diagnosis, good functional status at that time was significantly associated with long-term favourable outcome [OR 0.01, 95% CI (<0.01–0.03)]. Twenty-five patients (10.2%) died after the first year, with mortality associated with higher lesion burden at diagnosis and primary immunodeficiency as underlying disease. Even beyond the first year, PML remained the leading cause of death (11/25). Recurrence occurred in seven patients (2.9%) and was almost always fatal (6/7). This study provides a comprehensive evaluation of long-term outcomes among survivors of PML. These findings present a nuanced picture: while most remain neurologically impaired, nearly half achieve functional independence at 3 years. The results emphasize the prognostic relevance of the initial clinical and radiological burden and early functional trajectory and highlight the need for research into mechanisms driving disease recurrence.

1 June 2019 in Medecine Et Maladies Infectieuses
Verified
Journal Article
Closed access
ACA. Couturier
A. Couturier
FDF. Desbiez
F. Desbiez
PLP. Letertre-Gilbert
P. Letertre-Gilbert
NMN. Mrozek
N. Mrozek
MVM. Vidal
M. Vidal
OLO. Lesens
O. Lesens